Apyx Medical Corporation (NASDAQ:APYX) Q2 2024 Earnings Call Transcript
Operator: Hello, and welcome, ladies and gentlemen, to the Second Quarter of Fiscal Year 2024 Earnings Conference Call for Apyx Medical Corporation.
Apyx Medical Corp (APYX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Archon Capital Management Constantinos J. Christofilis | 3,115,281 | $4,174,477 | -10% | 3.38% |
| 2. | Royce & Associates Chuck Royce | 2,497,223 | $3,346,279 | +3% | 0.03% |
| 3. | Horizon Asset Management Murray Stahl | 615,000 | $824,100 | 0.01% | |
| 4. | Renaissance Technologies Jim Simons | 216,593 | $290,235 | -15% | 0% |
| 5. | 23,000 | $30,820 | +44% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.13 | 5,336 | Officer | 7,836 | 2024-08-13 | Filing | |
| $2.19 | 2,500 | Officer | 2,500 | 2023-12-12 | Filing | |
| $1.57 | 50,000 | Officer, Director | 90,000 | 2023-11-14 | Filing | |
| $5.97 | 9,750 | Officer, Director | 40,000 | 2022-08-29 | Filing | |
| $5.93 | 2,000 | Officer, Director | 30,250 | 2022-08-29 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.56 | 15,000 | Officer | 0 | 2023-06-26 | Filing | |
| $7.56 | 15,000 | Officer | 40 | 2023-06-26 | Filing | |
| $2.40 | 750 | Director | 1,750 | 2011-12-23 | Filing | |
| $2.87 | 5,000 | Director | 261,508 | 2011-06-08 | Filing | |
| $2.99 | 800 | Director | 2,500 | 2011-05-20 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,480,884 | $3,879,916 | 0% | |
| 2. | 1,025,963 | $2,688,023 | 0.04% | |
| 3. | 638,965 | $1,674,088 | 0.84% | |
| 4. | 613,880 | $1,608,366 | 1.53% | |
| 5. | 608,628 | $1,594,605 | 0% |
News See All
Apyx Medical Corporation (NASDAQ:APYX) Q1 2024 Earnings Call Transcript
Operator: Hello, and welcome, ladies and gentlemen, to the First Quarter of Fiscal Year 2024 Earnings Conference Call for Apyx Medical Corporation. [Operator Instructions].
Apyx Medical Corporation (NASDAQ:APYX) Q4 2023 Earnings Call Transcript
Apyx Medical Corporation misses on earnings expectations. Reported EPS is $-0.28 EPS, expectations were $-0.13.
Apyx Medical Corporation (NASDAQ:APYX) Q3 2023 Earnings Call Transcript
Operator: Please stand by. Hello, and welcome, ladies and gentlemen, to the Third Quarter of Fiscal Year 2023 Earnings Conference Call for Apyx Medical Corporation.
Apyx Medical Corporation (NASDAQ:APYX) Q2 2023 Earnings Call Transcript
Operator: Hello, and welcome, ladies and gentlemen, to the Second Quarter of Fiscal 2023 Earnings Conference Call for Apyx Medical Corporation.
Apyx Medical Corporation (NASDAQ:APYX) Q1 2023 Earnings Call Transcript
Operator: Hello and welcome, ladies and gentlemen, to the First Quarter of Fiscal Year 2023 Earnings Conference Call for Apyx Medical Corporation.
Apyx Medical Corporation (NASDAQ:APYX) Q4 2022 Earnings Call Transcript
Operator: Please stand by. Hello and welcome, ladies and gentlemen to Fourth Quarter and Fiscal Year 2022 Earnings Conference Call for Apyx Medical Corporation.
10 Best Medical Stocks Under $10
While the COVID-19 virus spread worldwide, the medical industry proved its resilience and capacity to bring life-saving products to market promptly.
Where Do Hedge Funds Stand On Apyx Medical Corporation (APYX)?
In this article we are going to use hedge fund sentiment as a tool and determine whether Apyx Medical Corporation (NASDAQ:APYX) is a good investment right now.
Here is What Hedge Funds Think About Apyx Medical Corporation (APYX)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Billionaire Hedge Funds
